Article Details
Retrieved on: 2022-06-16 14:23:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The study of 252 people tested whether the pharmaceutical giant Roche's antibody crenezumab could slow or halt the disease if participants took ...
Article found on: www.usatoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here